Peter Goodhand

Last updated

Peter Goodhand is a senior executive and board member in the health research advancement community.

Contents

Career

Starting in the UK in 1980 and moving to North America in 1986, Goodhand had a 20-year career in the global medical technology industry, including international leadership roles with American Cyanamid and Johnson & Johnson. [1]

From 2000 to 2003 he served as the board chair and president of the Canadian Medical Device Technology Association (MEDEC) and presented MEDEC's submission to the Senate Standing Committee on Science and Technology in October 2001. [2]

In 2003 he became the founding managing director of the Health Technology Exchange (HTX) [3] and the chairman of the board in 2004. [4]

In 2004 he joined the Ontario Division of the Canadian Cancer Society as its CEO and in 2009 became the national president and CEO. [5] [6]

In 2009 he chaired the Government of Canada’s Expert working group on the future of medical isotope production, [7] and in September 2011 was a member of the Canadian delegation to the first UN High Level Meeting on non-communicable diseases. [8]

From 2012 to 2013 Goodhand played a key role in the creation of a global alliance to accelerate progress in genomic research and medicine and in 2014 became the founding executive director of the Global Alliance for Genomics and Health (GA4GH). [9] [10]

As a volunteer he is currently chair of the board HTX; chair of the steering committee of the Occupational Cancer Research Center; [11] Chair of the industry advisory committee and board member of the AGE-WELL National Centre of Excellence; [12] Board Member, MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation); [13] and a member of the Scientific and Medical Advisory board of Global Genes - Allies in Rare Disease. [14]

Awards

2006, The Heather Crowe Award from the Ontario Government for leadership in advocacy in tobacco control. [15]

2014, The Champions of Hope Award from Global Genes. [16]

2015, The Outstanding Canadian Distinction Award from the Health Charities Coalition of Canada. [17]

Related Research Articles

James Orbinski

James Jude Orbinski, is a Canadian physician, humanitarian activist, author and leading scholar in global health. Orbinski was the 2016-17 Fulbright Visiting Professor at the University of California, Irvine, and as of September 1, 2017, he is professor and inaugural director of the Dahdaleh Institute of Global Health Research at York University in Toronto, Ontario, Canada. He was previously the CIGI Chair in Global Health Governance at the Balsillie School of International Affairs and Wilfrid Laurier University (2012-2017), Chair of Global Health at the Dalla Lana School of Public Health (2010-2012) and full professor at the Faculty of Medicine, University of Toronto (2003-2012), where he was the founding Saul Rae Fellow at Massey College. Orbinski’s current research interests focus on the health impacts of climate change, medical humanitarianism, intervention strategies around emerging and re-emerging infectious diseases, and global health governance.

Harold E. Varmus American scientist (born 1939)

Harold Eliot Varmus is an American Nobel Prize-winning scientist who was director of the National Institutes of Health from 1993 to 1999 and the 14th Director of the National Cancer Institute from 2010 to 2015, a post to which he was appointed by President Barack Obama. He was a co-recipient of the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviral oncogenes. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

Christopher David Naylor, is a Canadian physician, medical researcher and former president of the University of Toronto. He is ICES scientist emeritus and founding CEO. In 2016, he was inducted into the Canadian Medical Hall of Fame.

Joseph Louis Rotman,, was a noted Canadian businessman and philanthropist. Rotman was the founder, benefactor and member of many successful organizations, such as the Clairvest Group Inc., the Rotman Research Institute, the Rotman School of Management, and the Rotman Institute of Philosophy. Throughout his life, he received three honorary degrees, as well as an induction into the Canadian Business Hall of Fame. He is well-regarded for donating his time and financial assistance to numerous philanthropic causes including the arts, education and healthcare.

The Centre for Applied Genomics is a genome centre in the Research Institute of The Hospital for Sick Children, and is affiliated with the University of Toronto. TCAG also operates as a Science and Technology Innovation Centre of Genome Canada, with an emphasis on next-generation sequencing (NGS) and bioinformatics support. Research at TCAG focuses on the genetic and genomic basis of human variability, health and disease, including research on the genetics of autism spectrum disorder and structural variation of the human genome. The centre is located in the Peter Gilgan Centre for Research and Learning in downtown Toronto, Canada.

Sir John Irving Bell is a Canadian immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but as of 2020 is just a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.

Edison Liu

Edison T. Liu, M.D., is the president and CEO of The Jackson Laboratory, and was the president of Human Genome Organization, HUGO from 2007-2013.

Mark J. Poznansky

Mark J. Poznansky is a research scientist, science administrator and science blogger. He is the past president and CEO of the Ontario Genomics Institute (OGI) and was previously chair of the board of OGI, and the founder of G2G Consulting Inc. He is a member of the Order of Canada, a member of the Order of Ontario and was CEO, president and scientific director of Robarts Research Institute.

Sharon F. Terry

Sharon F. Terry is a health advocate in Washington, D.C. She co-founded PXE International when her children were diagnosed with pseudoxanthoma elasticum (PXE) in 1994. Her TEDMED talk has been viewed more than a million times in 2017, and was the subject of the TED Radio Hour. In 2009, she was elected an Ashoka Fellow for her entrepreneurial work in engagement and the development of interventions for genetic conditions.

Alan Bernstein is president and CEO of CIFAR. He is recognized as a leader in health research, science policy, mentorship and organizational leadership.

Gary Birch (electrical engineer)

Dr. Gary Birch, is a Canadian Paralympian, an expert in Brain-Computer Interface (BCI) technology and Executive Director of the Neil Squire Society. In 1975, Dr. Birch was involved in an automobile accident which resulted in injuries to the C6 and C7 area of his spine making him a low-level quadriplegic. He was one of the original players of Murderball, and won several medals in the 1980 Summer Paralympics in the Netherlands. In 2008, he was appointed an Officer of the Order of Canada. He continues to champion accessibility through his Research and Development work in assistive technologies at the University of British Columbia, the Rick Hansen Institute, and the Neil Squire Society.

Dr. Abdallah Daar is an Emeritus Professor of Clinical Public Health, Global Health, and Surgery at the University of Toronto. He has also been a Senior Scientist at the Research Institutes of University Health Network/Toronto General Hospital Research Institute, and the Hospital for SickKids. At the University of Toronto Joint Centre for Bioethics, from 2001 to 2007, he was Co-Director of the Canadian Program on Genomics and Global Health, and Director of the University of Toronto Program in Applied Ethics and Biotechnology. At the Sandra Rotman Centre, he was Director of Ethics and Commercialization.

Jeremy Farrar Epidemiologist and director of the Wellcome Trust

Sir Jeremy James Farrar is a British medical researcher and director of the Wellcome Trust since 2013. He was previously a professor of tropical medicine at the University of Oxford.

The International Human Epigenome Consortium (IHEC) is a scientific organization, founded in 2010, that helps to coordinate global efforts in the field of Epigenomics. The initial goal was to generate at least 1,000 reference (baseline) human epigenomes from different types of normal and disease-related human cell types.

Genomics England

Genomics England is a company set up and owned by the Department of Health and Social Care to run the 100,000 Genomes Project, which aimed in 2014 to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. An infectious disease strand is being led by Public Health England.

Professor Colleen Nelson is a scientist in prostate cancer research. Professor Nelson founded and directs the Australian Prostate Cancer Research Centre - Queensland (APCRC-Q). The Centre, based at the Translational Research Institute and the Princess Alexandra Hospital, spans the spectrum of discovery of new therapeutic targets and their preclinical and clinical development. Professor Nelson is also Chair of Prostate Cancer Research at Queensland University of Technology (QUT).

Frances Alice Shepherd, is a Canadian oncologist recognized for her research on lung cancer and her contributions to the design, development, and conduct of clinical trials. She is currently a senior staff physician at Princess Margaret Cancer Centre, where she has held the Scott Taylor Chair in Lung Cancer Research since 2001, and she is a full professor in the Department of Medicine at the University of Toronto.

May Cohen, OC is a Canadian physician and educator. She is best known for initiating the creation of a women’s health curriculum in Ontario medical schools and for her work as a women’s health advocate.

Jean-Robert Bernier, OMM, was the 38th Canadian Surgeon General and chief medical adviser to the North Atlantic Alliance as the 7th chairman of NATO's committee of Surgeons General (COMEDS).

The Global Alliance for Genomics and Health (GA4GH) is an international consortium that is developing standards for responsibly collecting, storing, analyzing, and sharing genomic data in order to enable an "internet of genomics".

References

  1. ↑ "Peter C. Goodhand | Global Alliance for Genomics and Health". genomicsandhealth.org. Retrieved 2015-08-20.
  2. ↑ "Proceedings of the Standing Senate Committee on Social Affairs, Science and Technology". Parliament of Canada.
  3. ↑ "Peter Goodhand" . Retrieved 2015-08-20.
  4. ↑ "OCRC |". www.occupationalcancer.ca. Retrieved 2015-08-20.
  5. ↑ "Globeinvestor.com: Appointment Notice - Canadian Cancer Society, Ontario Division: Peter C. Goodhand, Chief Executive Officer". www.globeinvestor.com. Retrieved 2015-08-20.
  6. ↑ "June | 2009 | Canadian Partnership Against CancerEN". www.partnershipagainstcancer.ca. Retrieved 2015-08-18.
  7. ↑ "$1.2-billion reactor needed for isotopes, Ottawa told" . Retrieved 2015-08-18.
  8. ↑ "Archived - Expert Panel Delivers Report on Isotopes". Government of Canada.
  9. ↑ "Peter Goodhand". Global Alliance for Genomics and Health.
  10. ↑ Picard, Andre (June 5, 2013). "New alliance aims to create international system for sharing genomic data". The Globe and Mail. Retrieved August 18, 2015.
  11. ↑ "OCRC | Steering Committee". www.occupationalcancer.ca. Retrieved 2015-08-18.
  12. ↑ "Peter Goodhand". AgeWell.
  13. ↑ "The EXCITE Management Board - MaRS" . Retrieved 2015-08-20.
  14. ↑ "Medical & Scientific Advisory Board" . Retrieved 2015-08-20.
  15. ↑ "HOUSE STATEMENT". www.mhp.gov.on.ca. Retrieved 2015-08-20.
  16. ↑ "2014 RARE Champions of Hope Honorees". Global Genes. Retrieved 20 August 2015.
  17. ↑ "Health Policy Canada | Health Charities Canada | Award of Distinction". www.healthcharities.ca. Retrieved 2015-09-15.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.